Carolyn provides the scientific research and analysis necessary for patent matters involving drugs and other pharmaceutical products.
Working closely with attorneys, Carolyn assists with patent prosecution, including for companies filing Abbreviated New Drug Applications (ANDA), and supports litigation over pharmaceutical intellectual property. Much of this work centers on the Hatch-Waxman Act, as well as on evaluating whether patents meet the standards for patentability. Carolyn also supports cases involving psychedelic drugs and therapies, drawing on her own research experience in psychoactive natural products and drug addiction. She regularly assists pharmaceutical companies, manufacturers, and drug developers of all sizes.
Driven by a lifelong love of scientific research and learning and a passion for both medicinal drugs and drug addiction treatment, Carolyn earned a Ph.D. in medicinal chemistry. She has held research roles in industrial, academic, and federal government laboratories, including time at the NIH’s National Institute on Drug Abuse, and she has also provided consulting work to psychedelic treatment nonprofits. Her broad perspective gives her a practical understanding of the challenges faced by a range of clients in the pharmaceutical and biotech sectors. Carolyn has also published extensively as a researcher and co-created artwork for several American Chemical Society journal issues—experience that taught her how to make complex scientific concepts clear and accessible.
Carolyn’s interest in patent law began as a coinventor on a patent during graduate school, sparking curiosity about the legal side of innovation. Her lab roles always included opportunities to present complex science to different audiences, a skill she now uses to clarify technical details for attorneys, clients, and patent examiners. Carolyn loves helping protect scientific advances and supporting clients by making the science behind their innovations clear and accessible.